It was also previously reported that the high expression of MT, including MT1 and MT2, in the cancer nest was associated with clinicopathological factors and poor prognosis based on immunohistochemical evaluation in ESCC tissues [55]. The gene discussed is MT2A; the disease is esophageal squamous cell carcinoma.